Welcome to the liver cancer page!

Whether you or someone you love has liver cancer, you've come to the right place!

Bookmark us now for the latest infomation on liver cancer research, liver cancer remedies, liver cancer risk, liver cancer prevention, screening, symptoms, diagnois, treatment and support for all people that have liver cancer

Liver Cancer Overview

What is Liver Cancer?

The liver is the largest internal organ of the body. It weighs about 3 pounds and accounts for about 2% of a person's body weight. It is sheltered by the lower right ribs and it is found underneath the right lung, separated from it by a muscle known as the diaphragm. It is shaped like a pyramid and divided into right and left lobes. Each of these lobes is further divided into segments. The liver, unlike most other organs, receives blood form two sources. The hepatic artery supplies the liver with blood that is rich in oxygen. The portal vein carries nutrient-rich blood from the intestines to the liver.

Because the liver is involved in many important metabolic functions, a person cannot survive without a liver. Some nutrients and vitamins absorbed by the intestines are stored in the liver until other organs need them. Other nutrients must be metabolized (chemically changed) in the liver before they can be used by the body for energy or to build and repair tissues.

Carbohydrate, protein, and lipid metabolism all depend on proper liver function. Blood levels of glucose and controlled by the liver. Glucose is a type of sugar that serves as the main source of energy for most tissues and organs in the body. The lover produces albumin. Albumin is a blood protein with several essential functions that include keeping a proper balance of fluid between tissues and the bloodstream, and transporting many hormones and drugs through the bloodstream. Several clotting factors are made in the liver. Without these factors to plug up damaged blood vessels, even small cuts or scrapes would cause life-threatening bleeding. Without amino acid metabolism by the liver, other tissues of the body could not produce the structural proteins of our bones and connective tissues or enzymes (proteins that regulate nearly all chemical processes of the body). The lover also plays a part on the metabolism of lipids (fats) and makes cholesterol, which is an essential part of the membranes that surround all cells and divide the cells into organelles (specific parts of cells). The liver also inactivates many drugs and toxic chemicals. If the liver is not working well, these substances can build up and interfere with many of the body's functions. The liver also produces bile, which is needed for the intestines to absorb certain nutrients.

Types of Liver Tumors

There are several types of malignant (cancerous) and benign (non-cancerous) tumors that con form in the liver. Because these tumors have different causes, are treated differently, and have a different prognosis (outlook for survival), it is important to briefly review their names. Several different types of cells form the liver. Different tumors can start in any of these cell types. The most common type of benign liver tumor starts in blood vessels. It is called a hemangoima. Most hemangiomas of the liver cause no symptoms. Some may cause blood loss. This type of tumor can be cured by surgical removal. Hepaticadenomas are benign tumors that start from hepatocytes (the main type of liver cell). Most cause no symptoms but some cause abdominal (stomach area) pain, an increased by long-term use of oral contraceptives (birth control pills). This type of tumor can be cured by surgical removal. Hepaticadenomas are benign tumors that start from hepatocytes (the main type of liver cell). Most cause no symptoms but some cause abdominal (stomach area) pain, a mass in the abdomen, or blood loss. The risk of having a hepatic adenoma is increased by ling-term use of oral contraceptives ( birth control pills). This type of tumor can be cured by surgical removal. Focal nodular hyperplasia (FNH) is a tumor-like growth of several cell types (hepatocytes, bile duct cells, and connective tissues.). FNH is also cured by surgical removal. Both FNH and hepatic adenomas are more common in women that in men.

There are four main types of malignant liver tumors: Angiosarcomas or hemangiosarcomas begin from blood vessels of the liver. The risk of developing an angiosarcoma is greatly increased by exposure to vinyl chloride or to thorium dioxide (Thorotrast). Vinyl chloride is a chemical used in manufacturing some kinds of plastics. In the past, Thorotrast was a chemical injected into some patients as part of a certain x-ray test. Once the cancer-causing properties of these chemicals were recognized, steps were taken to eliminate or reduce the risk. Workers exposed to vinyl chloride are strictly regulated, and plastics manufacturing processes have been changed to lower exposure. Medical use of Thorotrast was stopped about 50 years ago. Angiosarcomas of the liver are rare, accounting for about 1% of liver cancers. Unfortunately, they grow rapidly and are usually too widespread to be removed surgically by the time they are found. Chemotherapy and radiation therapy does not help much. The typical patient survives less than 6 months after diagnosis. Cholangiocarcinoma is a type of adenocarcinoma (malignant glandular tumor) that starts in small bile ducts within the liver. About 13% of primary liver cancers are cholangiosarcomas. People with gallstones are gallbladder inflammation, chronic ulcerative colitis (a longstanding inflammation of the large bowel), or chronic infection with Clonorchis sinensis (a parasitic worm found in parts of Asia) has an increased risk of developing this cancer. Signs and symptoms may include abdominal pain, liver enlargement, or jaundice (green-yellow coloration of the skin and eyes). Joundice without abdominal pain is most typical of cholangiocarcinomas that start near the hilum to the liver (the area where bile ducts exit the liver on their way to the gallbladder). Cholangiocarcinomas in that area also known as Klatskin tumors. Most cholangiocarcinomas cannot be completely removed by surgery, due to their size and location within the liver. Chemotherapy and radiation therapy is also not effective. For these reasons, their prognosis is poor, with an average survival after diagnosis of about 6 months. When possible, complete surgical removal is attempted. Surgery to bypass bile ducts blocked by cancer can temporarily relieve some symptoms. Hepatoblastoma is a rare type of liver cancer that is usually found in children less that 4 years old. Under the microscope, the cells of hepatoblastoma resemble embryonic or fetal liver cells. About 70% of children with this disease are treated successfully and the survival rate is over 90% for early stage hepatoblastomas. In contrast with most adult liver cancers, hepatoblastomas usually respond well to chemotherapy.

Hepatocellular carcinoma (also known as hepatoma or HCC) develops from hepatocytes (the main type of liver cell). It is the most common type of primary liver cancer (cancer beginning within the liver). HCC accounts for about 84% of primary liver cancers. For this reason, the remaining sections of this document refer only to HCC. There are several subtypes of HCC which appear slightly different when viewed under a microscope. The fibrolamellar subtype of HCC is the most significant of these. Patients with fibrolamellar HCC are usually younger than those with other subtypes. They are usually women and do not have diseases of their non-cancerous liver tissue. Most importantly this subtype is associated with a much better prognosis that other forms of HCC.

In contrast to primary liver cancers that form in the liver, metastatic or secondary liver tumors are those that develop in other organs (such as the pancreas, colon, stomach, breast, lung, etc.) and secondary metastasize (spread) to the liver. In the United States and Europe, secondary liver tumors are more common than primary liver cancer. The opposite is true for many areas of Asia and Africa.

Do We Know What Causes Liver Cancer?

Although several risk factors for HCC are known, the exact way in which these factors cause normal liver cells to become cancerous is only partially understood. Scientists believe that cancers develop in two steps: The first step requires damage to the DNA cells. DNA contains the instructions for nearly every chemical process in our bodies. Some of these instructions help cells to grow at a proper rate. If these instructions are altered, the cells may grow too much and form a tumor. Fortunately, our cells have the ability to repair our DNA, so that most DNA damage does not cause a cancer.

The second step in cancer formation requires cells to grow and divide. When cells divide shortly after their DNA is damaged, two new "daughter cells" may be formed before the original cell has time to repair its DNA damage. Both daughter cells will have the same DNA error. Once this happens, it is too late to repair the damage, which may eventually cause a cancer.

Certain chemicals that cause liver cancer, such as aflatoxins, are known to damage liver cells' DNA. Recent studies have shown that aflatoxins can damage the p53 gene. The DNA of these genes normally works to prevent cells from growing too much. Damage to the p53 DNA can lead to increased growth of cells and formation of cancers. Infection of liver cells with hepatitis viruses can also cause DNA damage. These viruses have their own DNA, which carries instructions on how to infect cells and produce more viruses. In some patients this viral DNA can become inserted into the liver cell's DNA. An insertion of virus DNA can cause confusion in the DNA instructions of a liver cell. If the virus interrupts instruction related to cell growth control, a cancer may be formed.

Cells of certain tissues such as blood, skin, and the intestinal lining constantly wear out and must be replaced. Under normal conditions, adult liver cells rarely wear out and rarely divide. Only a small fraction of liver cells undergo cell division in response to minor cell loss due to natural aging. However, if hepatitis viral infection, alcohol abuse, or iron accumulation damages the liver, cells can die. This leads the remaining liver cells to grow and divide.

This growth and division can pass damaged liver cell DNA (due to virus insertion, aflatoxin, or other causes) on to the new "daughter" liver cells before it can be repaired. The result is that cell instructions for growth control can be permanently altered, and a cancer may form.

Although scientists are making progress in understanding this process, there are still some points that are not completely understood. It is hoped that a more complete understanding will help in developing ways to better prevent and treat liver cancers.





liver Cancer News

4 Oct 2009 at 2:00am
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer.
2 Oct 2009 at 6:00am
One of the most common reasons for needing a liver transplant is liver failure or liver cancer caused by liver cell infection with hepatitis C virus (HCV). However, in nearly all patients the new liver becomes infected with HCV almost immediately.
5 Mar 2010 at 4:45am
Enlarged liver is a condition in which the size of the liver exceeds the normal size. This condition is also termed as Hepatomegaly. The presence of a large liver signify some crucial problem like some liver disease or cancer or even congestive heart failure. Jaundice is the major symptom for this condition. Enlarged Liver Symptoms: Some [...]
13 Dec 2009 at 10:00pm
A team of scientists from the UC San Diego School of Medicine and Osaka University in Japan have identified a protein switch that helps prevent liver damage, including inflammation, fibrosis and cancer. The findings suggest that a better understanding of how the protein, TAK1, works could lead to new insights into the development of liver disease and cancer.
7 Oct 2009 at 10:00pm
(Public Library of Science) Scientists have found that the human liver fluke (Opisthorchis viverrini) contributes to the development of bile duct (liver) cancer by secreting granulin, a growth hormone that is known to cause uncontrolled growth of cells. Details are published Oct. 9 in the open-access journal PLoS Pathogens.
28 Oct 2009 at 11:00am
Distinguished transplant and cancer surgeon, Alan Hemming, MD, has been recruited to the University of California, School of Medicine to launch a multidisciplinary center for the treatment of advanced liver disease at the UC San Diego Medical Center and Moores UCSD Cancer Center.
21 Jul 2009 at 7:00am
Two genes may contribute to chemotherapy resistance in drugs like 5-fluorouracil, which is used in liver cancer treatment, according to Virginia Commonwealth University Massey Cancer Center researchers. Liver cancer is a highly aggressive form that has limited therapeutic options. One of the key challenges with cancer treatment is that patients can develop resistance to chemotherapy.
12 Jun 2009 at 8:00am
In a study comparing two strains of mice, one susceptible to developing cancer and the other not, researchers found that a high-fat diet predisposed the cancer-susceptible strain to liver cancer, and that by switching to a low-fat diet early in the experiment, the same high-risk mice avoided the malignancy.
19 Nov 2009 at 10:00pm
In patients with unresectable (unable to be removed by surgery) liver cancer, an interventional radiology procedure called triple-drug transcatheter arterial chemoemobolization followed by a liver transplant may significantly increase a patient's chance of long-term survival, according to a study published in the December issue of the American Journal of Roentgenology.
4 Jul 2009 at 1:00am
Certain mutations in the DNA of the hepatitis B virus (HBV) are associated with the development of liver cancer and may help predict which patients with HBV infections are at increased risk of the disease, according to a large meta-analysis in the Journal of the National Cancer Institute, published online July 2.
15 Sep 2009 at 10:00pm
(Journal of the National Cancer Institute) A 20-year follow-up study revealed a dramatic drop in liver cancer cases among 6- to 19-year-olds who were vaccinated for the hepatitis B virus at birth, according to a study published online Sept. 16 in the Journal of the National Cancer Institute.
6 Oct 2009 at 7:00am
A recent study maps the pathway that leads from infection with Hepatitis B and C virus (HBV and HCV) to chronic hepatitis and liver cancer and proposes a new therapeutic strategy for treating liver diseases with chronic inflammation.
11 Oct 2009 at 2:00am
Scientists have found that the human liver fluke (Opisthorchis viverrini) contributes to the development of liver cancer by secreting granulin, a growth hormone that is known to cause uncontrolled cell growth.
1 Jul 2009 at 10:00pm
(Journal of the National Cancer Institute) Certain mutations in the DNA of the hepatitis B virus are associated with the development of liver cancer and may help predict which patients with HBV infections are at increased risk of the disease, according to a large meta-analysis in the Journal of the National Cancer Institute, published online July 2.
31 Jul 2009 at 4:00am
A new study investigated the effectiveness of S-adenosylmethionine (SAMe) in the prevention and treatment of hepatocellular carcinoma (HCC) or primary liver cancer. SAMe, a widely available nutritional supplement, with little known side effects, was found to be effective in preventing the formation of HCC in rats.